Variations in global prices of chemotherapy for childhood cancer: a descriptive analysis

ABSTRACT: Summary

Background

The stark disparity in survival for children with cancer across the world has inspired a global call to expand chemotherapy access in low and middle income countries. Among the numerous barriers to success, a paucity of reliable information regarding chemotherapy pricing hinders the ability of governments and other key stakeholders to make informed budget decisions or negotiate lower medication prices. The aim of this study was to generate comparative price information on both individual chemotherapy agents and comprehensive treatment regimens for common childhood cancers using real-world data.

Methods

Chemotherapy agents were selected based on their inclusion in the World Health Organization (WHO) Essential Medicines List for Children (EMLc) and their

SUBMITTER: Habashy C 

PROVIDER: S-EPMC10209684 | biostudies-literature | 2023 May

REPOSITORIES: biostudies-literature